Relebactam/Cilastatin/Imipenem (Recarbrio)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- October 2020
Comments
Treatment of infections due
to aerobic Gram-negative organisms in adults with limited treatment options - await NICE TA or clinician request search again
